The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 16th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Children with Lupus and Diabetes Are Likely to Also Have Depression
Children with systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD) often suffer from significant bouts of depression and potentially suicide ideation, a study in the Journal of Pediatrics determined.
Growing Evidence that Insulin Plays a Role in Etiology and Severity of Acne Vulgaris
A study in Postᶒpy adds to the growing evidence of a link between insulin and carbohydrate metabolism in the etiology and severity of acne vulgaris. While the clinical evidence on this connection is still disputed, the majority of recent studies has pointed to a significant connection between the condition and insulin levels.
FDA Warning: Disabling Joint Pain Seen in Diabetes Drugs
The US Food and Drug administration today issued a warning that the type 2 diabetes medicines sitagliptin (Januvia/Merck) linagliptin (Tradjenta/BI), and alogliptin (Nesina/Takeda) "may cause joint pain that can be severe and disabling."
Alopecia Areata Associated with Significant Comorbidities
A systematic review of alopecia areata (AA) in Clinical, Cosmetic & Investigational Dermatology highlighted the unpredictability and lack of treatment options for the condition. But it also pointed to a larger problem: more than half of patients with AA experience poor health-related quality of life (QOL). Patients with AA are at risk for depression and anxiety, atopy, vitiligo, thyroid disease, and other autoimmune conditions.
Pituitary Incidentaloma Treatment Guideline
August 21st 2015It is unclear how many people have pituitary incidentaloma, but imaging and autopsy studies indicate they are quite common and occur in up to one-third of patients. Fortunately, the vast majority of these serendipitously discovered tumors are clinically insignificant. A management guideline in the Annals of Endocrinology brings endocrinologists up to date on current thinking about pituitary incidentaloma management.
Fighting Fat with Fitbit, Text Messages, and Other Electronic Interventions to Promote Exercise
August 21st 2015Most self-improvement intervention programs rely on self-monitoring, or increased awareness of bad habits, to help people change their behaviors. Traditionally, programs have used diaries, calendar notes, or check-ins at daily or weekly meetings to help individuals recognize and replace unhelpful routines. The October 2015 issue of Telemedicine and e-Health includes a study that describes how simple electronic feedback can help people with weight problems.
Diagnosing and Treating Exocrine Pancreatic Insufficiency in Patients with Celiac Disease
New research concludes that the association between celiac disease and exocrine pancreatic insufficiency (EPI) is strong enough that physicians should check for EPI when celiac patients suffer malnutrition or gastric distress despite adherence to prescribed diets.
Patients with the cystic fibrosis transmembrane conductance regulator gating mutation G551D have insufficient ion transport due to reduced channel-open probability. New information suggests that increased ion transport reduces disease burden in the pancreas, which prevents cystic fibrosis patients from digesting food properly and leads to exocrine pancreatic insufficiency in up to 90% of all cases.
Tumor Necrosis Factor Inhibitors and NAFLD
August 11th 2015Nonalcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease reported in the United States. Some researchers have hypothesized that TNF-α, as a mediator of inflammation, might be a therapeutic target for NAFLD since inflammation seems to be a component of its etiology.
Ergocalciferol vs. Cholecalciferol in Pediatric Cystic Fibrosis Patients with Vitamin D Deficiency
A new trial of vitamin D replacement regimens in young people with cystic fibrosis and exocrine pancreatic insufficiency finds twice-weekly doses of vitamin D2 50,000 IU to be as effective as weekly doses of vitamin D3 50,000 IU.
After House Passage 21st Century Cures Act Awaits Senate Approval
With funding meant to bolster basic research and help make advances for a variety of conditions the fate of the 21st Century Cure Act is anything but secure even after passage by the US House of Representatives.
Studies Show Little to No Effect on Cardiovascular Health from Testosterone Replacement Therapy
At least 5 studies indicating that testosterone replacement therapy either has no effect on cardiovascular health -- or tends to improve it -- appeared during the 3-week period immediately after the US Food and Drug Administration's controversial decision to mandate warnings about the potential cardiovascular risks of such treatment.
The Effect of Relationship Status on Testosterone Levels in Men
Researchers have long known that single men tend to have more testosterone than comparable men in long-term relationships, but what about men in new relationships? A new study finds that testosterone generally remains at "single-man" levels until couples have been dating for more than a year.
Face-to-Face by Videoconference: Improving Diabetes Care
July 23rd 2015Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) project, a 4-year Centers for Medicare and Medicaid Services-sponsored demonstration project, showed that a telemedicine intervention can improve glycemic, lipid, and blood pressure control.
Dawn of a New Era? A Cardiologist Takes Stock of PCSK9 Inhibitors
Friday could be a big day for cardiologists. The FDA is due to rule July 24 on what could be the first available PCSK9 inhibitor, one of a new class of cholesterol-lowering agents meant to help patients who cannot get their LDL levels low enough with statins. New York City cardiologist David Vorchheimer, MD. talks about his hopes for the new drugs, and a few concerns
Understanding the Relationship between Chronic Pain and Obesity
Both chronic pain conditions and obesity are major and increasing public health concerns, and the connections between the two have been firmly established in the medical literature. But as the prevalence of obesity worldwide continues to grow, a deeper understanding of this connection could potentially benefit both practitioners and patients.
New Evidence Added to Strong Connection Between Depression and Diabetes Outcomes
A study evaluating glycemic response following insulin initiation for type 2 diabetes mellitus found that patients with higher depression parameters or distress at baseline had significantly higher rates of microvascular complications at baseline and higher HbA1c levels.